Standards & guidance

Filter Standards and Guidance documents

Page 4 of 13

FSRH CEU Guidance: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception (February 2023)

07 February 2023

This FSRH Guidance provides key information and good practice points for health professionals on drug-drug interactions (DDIs) between HIV antiretroviral therapy (ART) and contraception to facilitate the prescription of safe and effective contraception to people living with HIV and on ART.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH Service Standard on Obtaining Valid Consent - October 2022

11 October 2022

Read and download the new FSRH Service Standard on Obtaining Valid Consent, published in October 2022.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

Please read this guidance document in conjunction with any relevant clinical statements for this topic.

FSRH Guideline-related CPD Q&A: Progestogen-only Pills (August 2022)

23 August 2022

Login to view this document. 1 CPD credit can be claimed for reading the guidance. 1 CPD credit can be claimed for answering the questions.

This resource is available to members/candidates of FSRH.

This document is up-to-date

FSRH CEU Statement Response to Edelman 2022 (August 2022)

04 August 2022

A new study (Edelman 2022) adds to the evidence around use of LNG-EC by those with higher weight/BMI but does not give a clear enough picture to inform any change in guidance.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

Please read this guidance document in conjunction with any relevant clinical statements for this topic.

FSRH CEU Statement: Response to Endler 2022 (July 2022)

06 July 2022

A recently-published literature review considers the evidence around mechanism of action of levonorgestrel oral emergency contraception (LNG-EC). The findings support current FSRH guidance on emergency contraception, and are reassuring for those with ethical concerns about post-ovulation effects.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU Statement: Response to Heikinheimo 2022 (June 2022)

22 June 2022

This FSRH Statement responses to a recently published cohort study, which used information from Finnish databases, assessed incidence of confirmed venous thromboembolic (VTE) events in 2018/19 amongst the roughly 300,000 Finnish people aged 15-49 who were using hormonal contraception (HC) in 2017 (identified from the prescribing database) and age-matched controls who were not using hormonal contraception.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date